article thumbnail

Charles River launches initiative to reduce animal testing

Drug Discovery World

Charles River Laboratories International has launched its Alternative Methods Advancement Project (AMAP), an initiative focused on developing alternatives to reduce animal testing. AMAP initiatives include research projects confirming the safety and efficacy of alternatives – ensuring patient safety remains the priority.

article thumbnail

Kidney-tissue platforms could reduce animal testing in toxicology studies

Drug Discovery World

Kidney disease researchers at the University of Washington will use a multimillion-dollar federal grant to advance drug development platforms that would reduce reliance on animal tests. The post Kidney-tissue platforms could reduce animal testing in toxicology studies appeared first on Drug Discovery World (DDW).

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Low endotoxin biomaterials could help to reduce animal testing

Drug Discovery World

This can improve the validity of 3D in vitro models and help to reduce animal testing.” The post Low endotoxin biomaterials could help to reduce animal testing appeared first on Drug Discovery World (DDW).

article thumbnail

Benefits of Animal Testing: How Ethical Testing Aids Research

biobide

Animal testing has had an influential role in almost every medical breakthrough in the last 100 years. Further, animals are essential in assessing drugs and vaccine safety. Approximately 26 million animals are used in the USA every year for research purposes.

article thumbnail

Why Animal Testing Is Necessary and How to Reduce It

biobide

Animal testing for the benefit of medical and scientific research has been taking place for hundreds of years. However, testing on animals has always been and will continue to be an ethical issue.

article thumbnail

Separating the Hype from the Hyperbole Surrounding FDORA’s Alternatives to Animal Testing under the FD&C Act

FDA Law Blog: Drug Discovery

In effect, the revisions to the FD&C Act and the PHS Act are designed to encourage the use of alternatives to animal testing not eliminate animal testing in drug development. adequate to justify the proposed clinical testing.” The pre-existing statutory language did not require animal testing.

article thumbnail

4 ways ex vivo models offer Pharma better alternatives to animal testing

Reprocell

Pharma companies are legally required to test novel drugs in animal models before beginning human trials. And while animal testing has progressed thousands of therapeutics that we use today, it is not without its experimental and ethical downfalls.